NewAmsterdam Pharma Co N.V (NAMS) Gross Margin: 2023-2025
Historic Gross Margin for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Sep 2025 value amounting to 100.00%.
- NewAmsterdam Pharma Co N.V's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
- Per NewAmsterdam Pharma Co N.V's latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
- NewAmsterdam Pharma Co N.V's 5-year Gross Margin high stood at 158.80% for Q2 2023, and its period low was 100.00% during Q1 2023.
- Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 105.35%.
- Data for NewAmsterdam Pharma Co N.V's Gross Margin shows a maximum YoY tumbled of 5,880bps (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows NewAmsterdam Pharma Co N.V's Gross Margin stood at 100.00% in 2023, then remained steady at 100.00% in 2024, then remained steady at 100.00% in 2025.
- Its last three reported values are 100.00% in Q3 2025, 100.00% for Q2 2025, and 100.00% during Q1 2025.